360 related articles for article (PubMed ID: 23290791)
1. Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode.
Yatham LN; Fountoulakis KN; Rahman Z; Ammerman D; Fyans P; Marler SV; Baker RA; Carlson BX
J Affect Disord; 2013 May; 147(1-3):365-72. PubMed ID: 23290791
[TBL] [Abstract][Full Text] [Related]
2. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
Marcus R; Khan A; Rollin L; Morris B; Timko K; Carson W; Sanchez R
Bipolar Disord; 2011 Mar; 13(2):133-44. PubMed ID: 21443567
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole alone or in combination for acute mania.
Brown R; Taylor MJ; Geddes J
Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.
Vieta E; T'joen C; McQuade RD; Carson WH; Marcus RN; Sanchez R; Owen R; Nameche L
Am J Psychiatry; 2008 Oct; 165(10):1316-25. PubMed ID: 18381903
[TBL] [Abstract][Full Text] [Related]
6. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
Yatham LN
J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.
Keck PE; Calabrese JR; McQuade RD; Carson WH; Carlson BX; Rollin LM; Marcus RN; Sanchez R;
J Clin Psychiatry; 2006 Apr; 67(4):626-37. PubMed ID: 16669728
[TBL] [Abstract][Full Text] [Related]
9. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH;
J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.
Keck PE; Calabrese JR; McIntyre RS; McQuade RD; Carson WH; Eudicone JM; Carlson BX; Marcus RN; Sanchez R;
J Clin Psychiatry; 2007 Oct; 68(10):1480-91. PubMed ID: 17960961
[TBL] [Abstract][Full Text] [Related]
11. A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder.
El-Mallakh RS; Marcus R; Baudelet C; McQuade R; Carson WH; Owen R
J Affect Disord; 2012 Feb; 136(3):258-66. PubMed ID: 22209190
[TBL] [Abstract][Full Text] [Related]
12. Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine.
Kemp DE; De Hert M; Rahman Z; Fyans P; Eudicone JM; Marler SV; Baker RA; Carlson BX
J Affect Disord; 2013 May; 148(1):84-91. PubMed ID: 23261129
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.
Suppes T; Eudicone J; McQuade R; Pikalov A; Carlson B
J Affect Disord; 2008 Apr; 107(1-3):145-54. PubMed ID: 17904226
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial.
Woo YS; Bahk WM; Chung MY; Kim DH; Yoon BH; Lee JH; Ahn YM; Chung SK; Kim JG; Lee KH; Paik KC
Hum Psychopharmacol; 2011 Dec; 26(8):543-53. PubMed ID: 22134973
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
[TBL] [Abstract][Full Text] [Related]
16. Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations.
Wingård L; Bodén R; Brandt L; Tiihonen J; Tanskanen A; Kieler H; Andersen M; Reutfors J
J Affect Disord; 2017 Aug; 217():16-23. PubMed ID: 28364619
[TBL] [Abstract][Full Text] [Related]
17. Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: clinical and methodological implications.
Bowden CL; Karayal ON; Schwartz JH; Gundapaneni BK; O'Gorman C
J Affect Disord; 2013 Jan; 144(1-2):171-5. PubMed ID: 22999893
[TBL] [Abstract][Full Text] [Related]
18. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.
Findling RL; Nyilas M; Forbes RA; McQuade RD; Jin N; Iwamoto T; Ivanova S; Carson WH; Chang K
J Clin Psychiatry; 2009 Oct; 70(10):1441-51. PubMed ID: 19906348
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine in long-term treatment for bipolar disorder.
Cipriani A; Rendell JM; Geddes J
Cochrane Database Syst Rev; 2009 Jan; (1):CD004367. PubMed ID: 19160237
[TBL] [Abstract][Full Text] [Related]
20. Lithium vs valproate in the maintenance treatment of bipolar I disorder: A post- hoc analysis of a randomized double-blind placebo-controlled trial.
Kang MG; Qian H; Keramatian K; Chakrabarty T; Saraf G; Lam RW; Wong H; Yatham LN
Aust N Z J Psychiatry; 2020 Mar; 54(3):298-307. PubMed ID: 31845587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
